• Susan G. Komen® 2015 Breast Cancer Research Funding Targets Early-Career Investigators, New Therapies, Health Inequities, and Metastatic Disease

    Grants in 25 States and Eight Countries Sustain Komen Leadership in Breast Cancer Research

     — Susan G. Komen, the world’s largest nonprofit funder of breast cancer research, announced new grants to 124 researchers in 25 states and eight countries internationally, with about half of the grants targeted to early-career researchers squeezed by stagnation in federal research dollars.

    The 2015 research grants expand Komen’s ongoing commitment to funding early-career scientists, that is, recent graduates and those trying to establish independent research careers. This group has been hit especially hard by real-dollar declines of as much as 25 percent in federal research funding over the past decade.

    “We committed two years ago to do all that we can to ensure that talented early-career investigators remain in the breast cancer research field, while continuing our support for established researchers,” said Komen President and CEO Judith A. Salerno, M.D., M.S. “We cannot afford to lose talented scientists to other fields for lack of funding.”

    This year’s research slate brings Komen’s total research investment to more than $889 million since 1982, the largest of any nonprofit, and second only to the U.S. government.

    Grants from Komen’s nearly $36 million research portfolio – including more than $17.6 million in grants awarded to early-career investigators – span the entire cancer continuum from prevention to treatments for aggressive and metastatic disease. These include:

    - 36 grants to improve understanding of metastatic breast cancer
    - 18 grants investigating how tumors develop drug resistance
    - 19 grants related to the study of triple negative breast cancer – one of the most aggressive forms of the disease
    - 15 grants working to identify and understand biological and socio-economic health inequities
    - 13 grants seeking to develop new and novel therapies

    A full list of Komen’s 2015 research grants can be found here.*

    In addition to funding breast cancer research, Komen has invested more than $1.95 billion into community health outreach and global programs that serve hundreds of thousands of women and men annually through breast cancer health and support programs that screen, educate and provide financial, medical and psychosocial assistance.